Preventing osteoporotic bone loss in mice by promoting balanced bone remodeling through M-CSFRGD, a dual antagonist to c-FMS and αvβ3 receptors
Year: 2024
Type: article
Abstract: -HSA allows the maintenance of certain levels of bone formation and may be superior to treatments that induce osteoclast depletion.
Institution: Ben-Gurion University of the Negev
Language: English
Topic: Bone Metabolism and Diseases
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,260
OpenAlex ID: W4403633403